source
- A-Alpha Bio launches AI antibody data consortium with GSK, Boltz and partnersA-Alpha Bio, a spin‑out founded by David Baker, announced the creation of a new consortium focused on sharing antibody design data. The group aims to address a shortage of high‑quality data that b…
- FDA advisory panel to consider reclassifying several widely used peptidesAn FDA advisory committee is meeting this week to decide whether it will recommend reclassifying a group of popular peptide products. The discussion comes as the industry watches closely for any sh…